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Brominated and iodinated derivatives of 5,10,15,20-tetrakis(3-hydroxyphenyl)porphyrin were synthes-
ised directly from the corresponding aldehydes. Photophysical and photochemical properties, singlet
oxygen formation quantum yields, photobleaching and logP were measured. Cellular uptake measure-
ments and cytotoxicity assays on WiDr and A375 tumour cell lines were performed. 5,10,15,20-Tetra-
kis(2-bromo-5-hydroxyphenyl)porphyrin showed the best cytotoxicity with values of IC50 of 113 nM
over WiDr cells and 52 nM over A375 cells.
 2008 Elsevier B.V. All rights reserved.1. Introduction
Photodynamic therapy (PDT) is accepted as one of the several
methods available for cancer treatment. The generation of the ac-
tive oxygen species near the target and only in the presence of light
minimizes the particularly important side effects of the common
systemic drugs. Of course there are some problems associated with
the presence of a light sensitive drug, sensitizer, in the organism
and with the light dose required for the elimination of the cancer
cells which can damage normal cells. Therefore searching for sen-
sitizers which can reduce these secondary events is important. Due
to their unique photochemical characteristics, the porphyrin fam-
ily compounds are the major class of molecules used as sensitizers
in PDT [1–5]. The ability to penetrate cells, together with the
capacity for singlet oxygen generation are essential characteristics
of the sensitizer. Tetraarylporphyrins bearing hydroxyl substitu-
ents in the aryl group are described as good photodynamic agents.
For example, in Foscan, currently in clinical use, all four phenyl
groups have a hydroxyl substituent at the meta position [6,7].
One possible way to improve the therapeutic capability of the sen-
sitizers is through the heavy atom effect [8] as shown in aza-
dipyrromethene derivatives [9]. However, in vitro demonstration
of the heavy atom effect in porphyrins is not confirmed.
In this work we prepared several new halogenated porphyrins
(PS2–PS4) related to 5,10,15,20-tetrakis(3-hydroxyphenyl)por-
phyrin (PS1) in order to evaluate the heavy atom effect on thell rights reserved.
: +351 239826068.
salves).photophysical and photochemical properties, as well as the photo-
dynamic effect of these new sensitizers using two different cell
lines, WiDr human colon adenocarcinoma cells and melanoma
A375 cells.
2. Experimental
2.1. General
1H NMR spectra were recorded on 300 MHz Bruker-AMX spec-
trometer. Mass spectra of EI were obtained with GC-MSD HP 6890/
5973 and Finnigan Advantage for the MS(ESI) spectra. Elemental
analysis was carried out with a EA1108-CHNS-0 Fisons Instru-
ments elemental analyser. Absorption spectra were recorded with
a Hitachi U-2001 spectrophotometer. Fluence rates were measured
with X97 radiometer from Gigahertz-Optik. Irradiation for the pho-
todynamic treatment was made using a fluorescent light source
equipped with a red filter (kcut off < 560 nm).
2.2. Chemicals
Solvents were purified by standard methods before use. Dichlo-
romethane was dried over CaH2 and distilled. The chloroform was
neutralised with neutral active alumina. 9,10-Dimethylanthracene
(DMA) was acquired from Aldrich and used without further purifi-
cation. Methylene Blue was used as received (Riedel-de Haën).
1-Octanol was obtained from Merck. Pyrrole was distilled before
used. For column chromatography, Silica Gel 60–220–440 mesh/
0.035–0.070 mm, from Fluka was used. 3-Hydroxybenzaldehyde
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hydroxybenzaldehyde (2) [10] and 2,4,6-tribromo-3-hydroxybenz-
aldehyde (4) [11] were prepared by bromination in acetic acid as
described. Photofrin was kindly offered by the Gastroenterology
Service of the Hospitais da Universidade de Coimbra. BCA protein
assay from Pierce was used for the quantification of the protein.
2.3. Porphyrin synthesis
2.3.1. 4-Iodo-3-hydroxybenzaldehyde (3) [12]
To a solution of 3.6 g (0.0295 mol) of m-hydroxybenzaldehyde
in 40 mL of ammonia, a solution of 7.5 g (0.0300 mol) of iodine
in 100 mL of water with 22.5 g of potassium iodide is slowly added.
The solution is left for 1 h with stirring. Then a solution of HCl
(3 M) is added until a yellow precipitate is formed. At this time
the solution is still alkaline. The liquid is separated, the solution
is made acid by addition of HCl (3 M) and a white precipitate is
formed. Filtration and recrystallization from ethanol/water gives
2.8 g (38%) of 4-iodo-3-hydroxybenzaldehyde (3) m.p. 125 C.
1H NMR (300 MHz, CDCl3) d-ppm = 6.0 (1H, s, OH), 7.19 (1H, dd,
J = 8.0 Hz, J = 1.9 Hz), 7.45 (1H, d, J = 1.9 Hz), 7.89 (1H, d, J = 8.0 Hz),
9.93 (1H, s, CHO); EI-MS: m/z = 248 (M+).
2.3.2. 5,10,15,20-Tetrakis(3-hydroxyphenyl)porphyrin (PS1) (THPP)
3-Hydroxybenzaldehyde (0.61 g, 5.0 mmol) and pyrrole
(0.40 mL, 5.9 mmol) are added to 500 mL of degassed dichloro-
methane. One drop of ethanol followed by 10 lL of boron trifluoro-
boroetherate are added and the reaction is left to stand overnight.
The reaction is stopped by adding 0.025 mL of triethylamine. Pro-
pionic acid (60 mL) and 2 mL of hydrogen peroxide (30%) are added
and the solution concentrated in vacuo to a volume of 150–200 mL.
The solution is kept at 40 C with stirring until complete oxidation
(1–3 h). Organic acid is carefully extracted with water and the or-
ganic solution dried over sodium sulphate. The solvent is removed
by evaporation and the residue chromatographed on silica gel with
dichloromethane/ethyl acetate (2:1) (2% triethylamine) as mobile
phase, giving 100 mg (12%) of 5,10,15,20-tetrakis(3-hydroxy-
phenyl) porphyrin, which is recrystallized from dichloromethane/
cyclohexane giving purple crystals.
UV–vis (EtOH), (kmax nm). 415, 511, 545, 585, 643; 1H NMR
(300 MHz, CD3OD) d-ppm = 2.85 (2H, s, NH), 7.27–7.29 (4H, m,
Hphenyl), 7.52–7.57 (8H, m, Hphenyl), 7.68–7.72 (8H, m, Hphenyl),
8.50 (4H, s, OH), 8.90 (8H, s, Hpyrrole); ESI-MS: m/z = 679 (M+1)+;
C44H30O4N4: calcd. C, 77.86; H, 4.46; N, 8.25. Found: C, 78.23; H,
4.52; N, 8.30%.
2.3.3. 5,10,15,20-Tetrakis(2-bromo-5-hydroxyphenyl)porphyrin (PS2)
(TBr4HPP)
2-Bromo-5-hydroxybenzaldehyde (1.0 g, 5.0 mmol) and pyrrole
(0.34 mL, 5.9 mmol) are added to 500 mL of degassed dichloro-
methane. One drop of ethanol followed by 10 lL of boron trifluoro-
boroetherate is added and the reaction is left overnight. The
reaction is stopped by adding 0.025 mL of triethylamine. Acetic
acid (60 mL) and 2 mL of hydrogen peroxide (30%) are added and
the solution concentrated in vacuo to a volume of 150–200 mL.
The solution is kept at 40 C with stirring until complete oxidation
(0.5–1 h). Acetic acid is carefully extracted with water and the or-
ganic solution dried over sodium sulphate. The solvent is removed
and the residue chromatographed on silica gel with dichlorometh-
ane/ethyl acetate (2:1) (2% triethylamine) as mobile phase giving
120 mg (10%) 5,10,15,20-tetrakis(2-bromo-5-hydroxyphenyl) por-
phyrin, which is recrystallized from ethyl acetate/heptane giving
purple crystals.
UV–vis (EtOH), (kmax nm). 416, 512, 586, 646; 1H NMR
(300 MHz, CD3OD) d-ppm: 4.63 (4H, sl, OH), 7.19–7.30 (4H, m,
Hphenyl), 7.55–7.72 (4H, m, Hphenyl), 7.83–7.86 (4H, m, Hphenyl), 8.8(8H, s, Hpyrrole); ESI-MS: m/z = 994 (M+1)+; C44H26O4Br4N4  H2O:
calcd. C, 52.2; H, 2.79; N, 5.53. Found: C, 52.5; H, 3.13; N, 4.71%.
2.3.4. 5,10,15,20-Tetrakis(4-iodo-3-hydroxyphenyl)porphyrin (PS3)
(TI4HPP)
Using 4-iodo-3-hydroxybenzaldehyde and the cyclization–oxi-
dation procedure described above for PS2 we obtain a crude prod-
uct that is chromatographed on silica gel with dichloromethane/
ethyl acetate (1:1) (2% triethylamine) as mobile phase yielding
190 mg (13%) of 5,10,15,20-tetrakis(4-iodo-3-hydroxyphenyl) por-
phyrin as purple powder.
UV–vis (EtOH), (kmax nm). 418, 513, 548, 588, 645; 1H NMR
(300 MHz, CD3OD) d-ppm: 7.35 (4H, m, Hphenyl), 7.64 (4H, m,
Hphenyl), 7.82–7.99 (4H, m, Hphenyl), 8.91 (8H, s, Hpyrrole); ESI-MS:
m/z = 1183 (M+1)+; C44H26O4I4N4  4H2O: calcd. C, 42.1; H, 2.73;
N, 4.47. Found: C, 41.9; H, 2.35; N, 3.78%.
2.3.5. 5,10,15,20-Tetrakis(2,4,6-tribromo-3-hydroxyphenyl)porphyrin
(PS4) (TBr12HPP)
Using 2,4,6-tribromo-5-hydroxybenzaldehyde (1.87 g, 5.0 mmol)
and the cyclization–oxidation procedure described above for PS2
we obtain a crude product that is chromatographed on silica gel
with dichloromethane/ethyl acetate (1:1) (2% triethylamine) as
mobile phase yielding 150 mg (7%) 5,10,15,20-tetrakis(2,4,6-trib-
romo-5-hydroxyphenyl) porphyrin as a purple solid that was
recrystallized from chloroform/cyclohexane.
UV–vis (EtOH), (kmax nm). 418, 512, 589, 649; 1H NMR (CD3OD)
d-ppm = 2.74 (2H, bs, NH), 6.65 (4H, bs, OH), 8.20 (4H, m, Hphenyl),
7.70 (8H,s, Hpyrrole); ESI-MS:m/z = 1626 (M+1)+; C44H18N4O4Br12  2
CH3COOCH2CH3: calcd. C, 34.67; H, 1.90; N, 3.11; Found: C, 34.97;
H, 1.70; N, 3.14%.
2.4. Singlet oxygen quantum yield measurements
Photo-oxidation of 9,10-dimethylanthracene (DMA) was used
to determine the singlet oxygen formation quantum yield by the
sensitizers using steady state photolysis.
2.4.1. General procedure
One millilitre of DMA solution (1  104 M) and 2 mL of sensi-
tizer solution with O.D. at 417 nm, adjusted so that all the sensitiz-
ers absorb the same number of photons in the irradiated region
[13], were mixed in a quartz cell with 1 cm path. The sample
was air saturated and stirred magnetically to obtain uniform irra-
diation of the whole sample. The irradiation was performed using
a 50W halogen lamp, infrared radiation was filtered off through a
5 cm length water filter and wavelength range from 400 to 600 nm
was selected with appropriate glass filters. Absorption spectra of
DMA and the sensitizer solution is simply a superimposition of
the spectra of the separate components. DMA photo-oxidation
was monitored by the decrease in absorbance at 375 nm in etha-
nol. All the solutions were prepared and used without delay. THPP
(PS1) was used as standard in ethanol (UD = 0.50) [14].
Singlet oxygen quantum yields for the sensitizers were obtained
from the ratio between the slopes of the linear region of the semi-
logarithmic plot for the absorption decay of DMA (lnA0/A) versus
time, obtained by a linear least-squares fit when measured from
the solutions with the sensitizers and the reference under similar
conditions [14–18]. The pooled standard deviation of the kinetic
data, using different prepared samples, was less than 10%.
2.5. Photobleaching
The porphyrin photobleaching was measured using solutions in
H2O/PEG400/EtOH (50:30:20, v/v/v) with a 5  106 M concentra-
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says. The value of photodegradation was determined by UV–vis
spectroscopy from the decrease of the Soret band (B(0,0)) inten-
sity. The total irradiation time was 24 h and measurements were
made at 6 h intervals.2.6. Partition coefficient measurements
1-Octanol/water partition coefficients were determined at 25 C
using equal volumes, 3 mL, of water (buffered at pH = 8 using so-
dium tetraborate) and 1-octanol. Typically, 2 mg of sensitizer were
dissolved (using ultrasound when necessary) in the pre-equili-
brated mixture of solvents and vortexed for 10 min. The solutions
were left until the separation between the two phases was clear.
The absorption of the aqueous phase was directly measured and
the absorption of the solution in 1-octanol was measured from
100 lL/3 mL dilutions using UV–vis spectroscopy. The logP was
calculated from the ratio between the absorbance of the two sol-
vents [19].2.7. Cell culture conditions
The human colon carcinoma cell line WiDR and the human mel-
anoma cell line A375 were purchased from American Type Culture
Collection. The cell lines were cultured with Dulbecco’s Modified
Eagle medium (Sigma–Aldrich, Inc; Sigma D-5648) supplemented
with 10% heat-inactivated fetal bovine serum (Gibco Invitrogen
Life Technologies; Gibco 2010-04), 1% Penicillin–Streptomycin
(Gibco Invitrogen Life Technologies; 100 U/mL penicillin and
10 lg/mL streptomycin – Gibco 15140-122) and 100 lM sodium
pyruvate (Gibco Invitrogen Life Technologies; Gibco 1360) at
37 C, in a humidified incubator with 95% air and 5% CO2.2.8. Cellular uptake
Cells, 1  105, were incubated with solutions of the sensitizer of
5 lM, 1 lM and 0.5 lM concentrations for 24 h, released by tryp-
sinization and washed with cold PBS. To ensure full disaggregation
and cell rupture, 5 mL of methanol was added and the resulting
suspension left in the dark for 24 h. The fluorescence intensity of
the supernatant was determined by fluorescence spectroscopy
with a SPEX fluoromax 322-2 spectrophotometer using 410 nm
excitation wavelength. The intracellular concentration was deter-X
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2.9. Photodynamic treatment
For each experiment, cells were plated in 48 multiwells (Corn-
ing Costar Corp), in a concentration of 40,000 cells/mL and kept
in the incubator overnight, in order to allow the attachment of
the cells. The formulation of these sensitizers consisted in a
1 mg/mL solution in a ternary mixture of H2O/PEG400/EtOH
(50:30:20, v/v/v), the desired concentrations being achieved by
successive dilutions.
The sensitizers were administered in several concentrations
(50 nM, 250 nM, 500 nM, 1 lM, 5 lM, 10 lM) and cells were incu-
bated for 24 h. Cells were washed with PBS and new drug-free
medium was added. Each plate was irradiated with a fluence rate
of 7.5 mW/cm2 until a total of 10 J was reached. Cell viability
was measured 24 h after the photodynamic treatment.
2.10. Measurement of cell viability
The sensitivity of the cell lines to the sensitizers was analyzed
using the MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide, colorimetric assay (Sigma–Aldrich, Inc.; Sigma
M2128) to measure cell proliferation. Cytotoxicity was expressed
as the percentage of inhibition of cell proliferation correlated with
untreated cultures. This allows the calculation of the concentration
that inhibits the culture cell proliferation in 50% (IC50). Each exper-
iment was performed in duplicate and repeated in three sets of
tests.
3. Results
3.1. Synthesis of the sensitizers (PS1–PS4)
Hydroxyphenylporphyrins are usually synthesized from the
corresponding methoxyphenylporphyrins followed by standard
BBr3 demethylation. This strategy requires the use of the methoxyl
derivatives of the aldehydes which are prepared by methylation of
the corresponding hydroxybenzaldehydes. Our approach, replace-
ment of DDQ by hydrogen peroxide in the oxidative step of
porphyrinogens [20], allows to obtain the hydroxyphenylporphy-
rins directly from the hydroxylated aldehydes. Although giving
lower yields, in our approach two synthetic steps are avoided,Acetic acid/H2O2Y
N
NH N
HN
X
HO
X
HO
Z
Z
X
Y
Y
Z
Y
Z
X
Y
OH
OH
PS1- THPP: X=Y=Z=H             (η=10%)
PS2- TBr4HPP: X=Br; Z,Y=H   (η=10%)
PS3- TI4HPP: Y=I; X,Z=H         (η=13%)
PS4- TBr12HPP: X=Y=Z=Br       (η=7%)
porphyrin
ensitizers PS1–PS4.
Table 2
Singlet oxygen formation quantum yields, photobleaching and IC50 values for

64 A.C. Serra et al. / Journal of Photochemistry and Photobiology B: Biology 92 (2008) 61–67
ARTICLE IN PRESSthe protection of the aldehydes and the final deprotection of the
porphyrins Scheme 1.sensitizers PS1–PS4 and Photofrin
Porphyrin UD Photobleaching
(% of remaining sensitizer)
IC50
WiDr Cells A375 cells
THPP, PS1 0.50 42 143 nM 115 nM
TBr4HPP, PS2 0.55 67 113 nM 52 nM
TI4HPP, PS3 0.58 22 >10 lM 2.3 lM
TBr12HPP, PS4 0.50 19 >10 lM >10 lM
Photofrin 0.53[36] nda 666 nM 156 nM
a Not determined.3.2. Photophysical and photochemical properties
The absorption spectra of porphyrins in ethanol show the typi-
cal Soret (B(0,0) band) and Q-bands of these compounds [21]. The
absorption maxima and absorption coefficients of the sensitizers
are presented in Table 1. For concentrations between 1  107
and 1  104 M no deviation of the Beer–Lambert law was ob-
served indicating that the sensitizers are not aggregated under
the experimental conditions. Fig. 1 shows the normalised UV–vis
spectra of TBr4HPP, TBr12HPP, TI4HPP.
Singlet oxygen formation quantum yield, UD, was measured by
steady state photolysis using DMA as target. This compound was
used in order to calculate the singlet oxygen formation quantum
yield of different porphyrins and related compounds [14]. DMA
seems to be the best choice because it reacts selectively with
O2(1Dg), the reaction has a large rate constant in water and in many
organic solvents [17,22–24], does not present significant photoble-
aching, the observation of the photo-oxidation of DMA using UV–
vis spectroscopy is possible without interference of the sensitizer
absorption, and the process of photo-oxidation in the presence of
sensitizer follows first order kinetics.
With our steady state photolysis system we calculated 0.82 for
the UD of Rose Bengal using Methylene Blue as reference and DMA
as target in ethanol, the values from the literature differ between
0.68 and 0.86 [14]. Using the photo-oxidation of DMA in ethanol,
and THPP (PS1) as reference, we calculated the singlet oxygen for-
mation quantum yields, Table 2.Table 1
Absorption characteristics of sensitizers in ethanol
kmax(nm) e (M1 cm1)
B(0–0) Qx(1–0) Qy(1–0) Qx(0–0) Qy(0–0)
THPP, PS1 415 511 545 585 643
1.12  105 1,21  104 7.63  103 6.38  103 4.64  103
TBr4HPP, PS2 416 512 540 (shoulder) 586 646
1.93  105 1.24  104 4.50  103 4.98  103 2.93  103
TI4HPP, PS3 418 513 548 588 645
2.20  105 1.30  104 6.07  103 5.03  103 3.10  103
TBr12HPP, PS4 418 512 540 (shoulder) 589 649
1.75  105 1.47  104 6.26  103 6.43  103 3.40  103
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Fig. 1. UV–vis normalised spectra of TBr4HPP, TBr12HPP, TI4HPP.There is an increment of the UD value with the incorporation of
one bromine atom in the ortho position, in TBr4HPP, as well as with
one iodine atom in the para position of each phenyl ring, TI4HPP.
With the presence twelve bromine atoms on the phenyl rings,
TBr12HPP, there is a decrease of UD, being the same as described
for THPP.
To study the photobleaching process we used the same experi-
mental conditions, namely, solvent, concentration of the solution
and light source, as those for the cytotoxicity assays. The absorp-
tion of the solutions was measured after 6, 12, 18 and 24 h of irra-
diation. The decrease in intensity, measured by UV–vis
spectroscopy, of THPP and TBr12HPP followed first order kinetics
but TBr4HPP and TI4HPP showed a more complex behaviour. The
photobleaching after completion of 24 h of irradiation is presented
in Table 2 as a percentage of the remaining porphyrin.
Using the shake flask methodology we determined logP, using
the aqueous phase buffered at pH 8, of THPP (PS1) as 2.02 and
3.54 for the sensitizer TBr4HPP (PS2). For PS3 and PS4 the concen-
tration in the aqueous phase is below the detection limit of UV–vis
spectroscopy.
3.3. Cellular uptake
The cellular uptake was dose-dependant, the fluorescence
intensity decreases with the concentration of the initial solution
of porphyrin used in incubation for all the sensitizers, as shown
in Fig. 2 for THPP. The milligrams of protein was determined for
12 wells with an initial amount of 105 cells and found to be statis-
tically independent (0.82 ± 0.23 mg/mL). In separated cellular
extraction experiments using 5 lM solutions the intracellular con-
centration was found to be 0.63 ± 0.15 lM for THPP, 1.88 ± 0.11 lM
for TBr4HPP, 3.84 ± 1.00 lM for TI4HPP and 2.89 ± 0.92 lM for
TBr12HPP, Fig. 3.600 620 640 660 680 700 720 740
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Fig. 2. Fluorescence spectra of THPP obtained after cellular extraction using drug
solutions of 5 lM, 1 lM and 0.5 lM.
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Fig. 4. Cell viability % for WiDr human colon adenocarcinoma cells using sensitizers
PS1–PS4 and Photofrin.
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Fig. 5. Cell viability % for melanoma A375 cells using sensitizers PS1–PS4 and
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Fig. 3. Cellular uptake of sensitizers PS1–PS4.
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The data of cell viability for different concentrations of sensi-
tizer and 10 J cm2 of fluence in WiDr human colon adenocarci-noma cells, is presented in Fig. 4 and the data corresponding to
the same experimental conditions using melanoma A375 cells, in
Fig. 5.
The IC50 values for dose/response curves for WiDr human colon
adenocarcinoma cells and melanoma A375 are reported in Table 2
as well as the values obtained for Photofrin as reference
compound.4. Discussion
PDT is an emerging treatment for diseases related to anomalous
cell growth. The value of the treatment is directly dependant on
the characteristics of the sensitizer. Searching for new sensitizers
is an objective pursued by several groups because the performance
of present drugs gives room for improvement.
Porphyrins with hydroxyl groups show good activity as sensi-
tizers for photodynamic therapy. The presence of the hydroxyl in
the meta position of the meso phenyl rings seems to enhance this
activity relatively to other positions [25]. Patrice and co-workers
reported a promising diaryl sensitizer with four hydroxyl groups
(two in each phenyl group) [26,27]. Banfi et al. studied a series of
5,10,15,20-tetraarylporphyrins and 5,15-diarylporphyrins with
different numbers of hydroxyl groups on the phenyl ring conclud-
ing that the compound with hydroxyl groups at the meta position
are the most active in PDT [28].
Halogenated porphyrins have been studied as sensitizers in
PDT; for fluorinated derivatives, superior photodynamic properties
have been observed [29–31]. With other halogen atoms some re-
ports confirmed the expected superior behaviour for singlet oxy-
gen formation, as expected from the heavy atom effect [8,32] but
photocytoxicity was not studied.
The increase of the number of halogens on the phenyl ring or
the substitution of bromine for iodine did not bring any significant
changes to the absorption characteristics of this type of sensitizers,
Table 1. For the halogenated derivatives, the more significant tran-
sition for PDT applications (Qy(0–0)), is slightly shifted to the red
accompanied by the decrease of the absorption coefficient.
The singlet oxygen formation quantum yield, Table 2, increases,
with the presence of four bromine (PS2) or iodine atoms (PS3) on
the phenyl ring of the porphyrin as expected due to an increase of
the spin–orbit coupling with the heavy atom effect. The decrease of
UD value with the insertion of more bromine atoms was already
predicted for the Zn(II) complex of halogenated methoxyporphy-
rins [8]. The substitution in both ortho and para positions (PS4)
has a negative effect on the singlet oxygen formation quantum
yield. It is possible that this type of substitution increases the for-
mation of the triplet state (ISC process) and also the radiationless
transition of its decay, decreasing the triplet lifetime and therefore
the interaction with oxygen.
The photobleaching of the sensitizer in photodynamic therapy
has received increasing attention because sensitizer destruction
could be a limiting factor of its activity [33,34]. Our sensitizers
show very different photobleaching rates, varying with the nature
and number of halogen atoms. At 24 h of irradiation the stability
order is PS2 > PS1 > PS3 > PS4, Table 2. The poor stability of PS3
and PS4 can be related to the liability of the halogen–carbon bond
in these sensitizers.
There is no significant photobleaching of these sensitizers under
conditions of cytotoxicity assays using 10 lM solutions. After the
irradiation time corresponding to these experiments we estimate
that the % of porphyrin remaining was 97% for THPP, 98% for
TBr4HPP, 92% for TI4HPP and 94% for TBr12HPP.
The difficulties for determining the octanol/water partition
coefficients of poorly amphiphilic porphyrins is already known
[28]. We determined the logP of two of our sensitizers PS1 and
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atoms in the structure of the sensitizer, this effect is predicted by
simple ACD/logP (ChemSketch 10.0) calculations and probably is
the reason for the incapability of the determination of logP of
the other two sensitizers.
The cellular uptake increases with the presence of the halogen
atom following the series: THPP < TBr4HPP < TI4HPP < TBr12HPP.
As described by others, there is a relation between the lipophilicity
and the cellular uptake but, as in our case, this is not directly re-
lated to the photodynamic effect. It seems that pharmacodynamic
effects have greater influence than the pharmacokinetics of the
porphyrins [35].
The sensitizers PS1 to PS4 showed no dark phototoxicity in
50 nM and 10 lM range of concentration. Only with irradiation of
red light did we observe cytotoxicity (Figs. 4 and 5). Curves for cell
viability for WiDr cells in PDT assays are generally shifted to the
right relatively to the corresponding curves for melanoma cells
for all sensitizers tested. This shows that WiDr cells are more resis-
tant than melanoma cells to PDT treatment. For WiDr cells, PS3
and PS4 are less active than Photofrin and PS1 and PS2 are more
active and the same behaviour of phototoxicity is observed in the
case of melanoma cells. For the two lines of cells, it is clear that
the brominated porphyrin PS2 presents more phototoxicity than
the non-halogenated PS1. From the curves of viability we can cal-
culate the IC50 for the sensitizers, Table 2.
The results showed that the porphyrin with four bromine atoms
(PS2) presents an IC50 of 113 nM, that is about six times less than
the IC50 of the Photofrin and 25% less than the non brominated
analog (PS1) against WiDr cell line. For melanoma cells PS2 has
an even lower IC50 (52 nM) that is about three times lower than
the IC50 for Photofrin and two times lower than that of PS1.
Analysis of these results, comparing with THPP (PS1), points out
that the iodine atoms in the para position increase the singlet oxy-
gen formation quantum yield and the cellular uptake and decrease
the photostability and the hydrophilicity of the molecule resulting
in a poor photodynamic effect with IC50 values greater than Photo-
frin. The same is observed for the porphyrin bearing twelve bro-
mine atoms. The presence of bromine atoms in the ortho
positions of the phenyl rings shows the best balance of properties,
increase of the singlet oxygen formation quantum yield, the cellu-
lar uptake, and photostability without major changes in the hydro-
philicity. This set of characteristics leads to a phototherapeutic
agent with better IC50 values against WiDr and A375 tumour cell
lines.5. Conclusion
Heavy atom effect was observed in the iodinated and bromi-
nated derivatives of THPP. The cytotoxicity over WiDr and A375 tu-
mour cell lines is not directly related to the UD values of the
sensitizers, probably because the solubility characteristics and
the relationships structure-media and cellular-interactions play
an important role in the cytotoxicity. The derivative with four bro-
mine atoms (PS2) shows high singlet oxygen formation quantum
yield (UD = 0.55), similar solubility as THPP, higher cellular uptake
and shows the best IC50 values, 113 nM for WiDr cells and 52 nM
for A375 cells.
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